Preclinical Molecular Imaging retweeted
📰 BREAKING: New imaging technique could spot patients with aggressive brain tumours who would benefit from #Immunotherapy
The immuno-PET imaging removes the need for a risky biopsy which means treatment for #Glioblastoma could be monitored and adjusted
icr.ac.uk/news-archive/new-i…
We met to discuss the role of nuclear medicine in the treatment of brain tumours! Nathalie Albert&Matthias Preusser thanks for organising such a fantastic meeting! – at Vienna, Austria
5
390
So incredibly proud of Dr Gitanjali Sharma! Viva passed with flying colours! Jason and Alan - thank you❤️!
EANM 2023 - Vienna. Great meeting!
I am excited as I presented the very first results of our recently initiated clinical study evaluating 89Zr-DFO-Atezolizumab in patients with newly diagnosed glioblastoma!
Preclinical Molecular Imaging retweeted
🔬NEWS: A new form of screening may improve survival rates among people with glioblastoma #BrainTumours by helping to identify those most likely to benefit from certain types of #immunotherapy.
This pre-clinical research was led by @PETImagingICR.
icr.ac.uk/news-archive/new-a…
Preclinical Molecular Imaging retweeted
Fantastic effort by Adam, who studies #ProstateCancer.
He's joined other ICR researchers, patients, ICR supporters, and Greg Rutherford and Erin Kennedy in taking on our race to #FinishCancer by collectively running 167,000 steps along the UK coastline.
icr.ac.uk/support-us/appeals…
Today I ran 9 km to support @ICR_London’s race to finish cancer across Golden Gardens Park (Seattle, US). Together we are imprinting the words ‘FINISH CANCER’ into the coastline, to represent the 167,000 lives lost to cancer each year in the UK.
Preclinical Molecular Imaging retweeted
A fantastic thread from @ErinWysocki on why her personal experience of cancer inspired her to take part in our new campaign and finish cancer. Thank you, Erin!
Very excited to share the paper that has been just published by my final year PhD student, Gitanjali Sharma 👏😊
mdpi.com/2335902
10
480
Preclinical Molecular Imaging retweeted
📢Call to Join the WIMIN Leadership Committee!
Enjoy our events at #WMIC? Want to get involved and help plan conference sessions and raise funds for attendees?
We are accepting applications to join our leadership committee, due Jan 13: surveymonkey.com/r/F88529Y
Preclinical Molecular Imaging retweeted
We are proud to award the titles of Professor and Reader to 11 researchers from across the ICR and @royalmarsdennhs!
Titles were awarded for achievements in scientific and research careers, academic excellence, teaching and learning, service, and leadership 🎉
Preclinical Molecular Imaging retweeted
Nowa metoda leczenia #rak.a?
Poznajcie prof. Gabrielę #Kramer-Marek, która w @Polityka_pl mówi, jak #fotoimmunoterapia może pomóc chorym i jak doszła do swoich odkryć w USA, Londynie i Gliwicach.
@NIO_PIB @ICR_London @PETImagingICR @projektpulsar
⬇️⬇️⬇️
polityka.pl/tygodnikpolityka…
Preclinical Molecular Imaging retweeted
Come join us! We’re looking for an experienced in vivo biologist / pharmacologist to lead our in vivo drug discovery team & join us in discovering new cancer therapeutics. Experience with a wide range of in vivo models required. 💊🐁🧬
candidates.perrettlaver.com/…
Preclinical Molecular Imaging retweeted
🧠 Today is #GlioblastomaAwarenessDay. Earlier this year, an ICR-led study in mice showed a revolutionary treatment called #Photoimmunotherapy could be used to treat this type of aggressive #BrainCancer 🔦
Find out how 👇
icr.ac.uk/news-archive/light…
#GBMDay #GBMAwarenessDay #GBM

ALT 'Light-activated cancer therapy shows promise in mice. Light-activated therapy injected into bloodstream. It travels to the brain and attaches to tumour within 1-3 hours. Shining a light on the area causes fluorescent component to glow, helping surgical removal of the tumour. Shining near-infrared light generates reactive molecules that kill remaining cancer cells and activate immune system.'
























